Skip to main content

Part of the book series: Respiratory Medicine ((RM))

  • 660 Accesses

Abstract

About 10% of children have severe persistent disease, and these children are at risk for many long-term adverse events related to their disease. Biologic therapy shows promise in reducing medication burden, decreasing severe exacerbations, and improving quality of life in both children and adults; but not all children meet eligibility criteria for one of these drugs and some do not respond. Moreover, these drugs are expensive, require frequent and long-term administration, and not all children who are eligible for therapy receive it. Bronchial thermoplasty (BTP) is a procedure which is FDA-approved for use in adults with severe asthma that delivers targeted radiofrequency energy to large airways, resulting in ablation of smooth muscle. It has been shown to decrease the frequency of severe exacerbations and healthcare utilization for several years following the procedure. Given the long-term efficacy and safety demonstrated in adults, it could be considered as an intervention in adolescents who have severe persistent disease despite treatment with targeted biologic therapies or those treated with high-dose inhaled corticosteroids and/or systemic corticosteroid treatment that do not qualify for biologic therapy. Future directions would include elucidation of factors that predict a response to BTP and are relevant to the adolescent population.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Centers for Disease Control and Prevention. 2014 National Health Interview Survey (NHIS) data; Table 4-1 Current asthma prevalence percents by age, United States: National Health Interview Survey [Available from: https://www.cdc.gov/asthma/nhis/2014/table4-1.htm.

  2. Ramratnam SK, Bacharier LB, Guilbert TW. Severe asthma in children. J Allergy Clin Immunol Pract. 2017;5(4):889–98.

    Article  Google Scholar 

  3. Wenzel S. Severe asthma in adults. Am J Respir Crit Care Med. 2005;172(2):149–60.

    Article  Google Scholar 

  4. Burg GT, Covar R, Oland AA, Guilbert TW. The tempest: difficult to control asthma in adolescence. J Allergy Clin Immunol Pract. 2018;6(3):738–48.

    Article  Google Scholar 

  5. Centers for Disease Control and Prevention. Asthma in the US [Available from: https://www.cdc.gov/vitalsigns/asthma/.

  6. Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–73.

    Article  CAS  Google Scholar 

  7. Moore WC, Bleecker ER, Curran-Everett D, Erzurum SC, Ameredes BT, Bacharier L, et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute’s Severe Asthma Research Program. J Allergy Clin Immunol. 2007;119(2):405–13.

    Article  Google Scholar 

  8. Asthmatx Inc. Alair Bronchial Thermoplasty System Operator’s Manual.

    Google Scholar 

  9. Genetech. FDA label for omalizumab [July 31, 2018]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/103976s5225lbl.pdf.

  10. Milgrom H, Berger W, Nayak A, Gupta N, Pollard S, McAlary M, et al. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab). Pediatrics. 2001;108(2):E36.

    Article  CAS  Google Scholar 

  11. Teva Pharmaceutical Industries Ltd. FDA label for reslizumab.

    Google Scholar 

  12. Ortega HG, Liu MC, Pavord ID, Brusselle GG, FitzGerald JM, Chetta A, et al. Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med. 2014;371(13):1198–207.

    Article  CAS  Google Scholar 

  13. GlaxoSmithKline. FDA label for mepolizumab [Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125526s004lbl.pdf.

  14. Castro M, Mathur S, Hargreave F, Boulet LP, Xie F, Young J, et al. Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study. Am J Respir Crit Care Med. 2011;184(10):1125–32.

    Article  CAS  Google Scholar 

  15. Lai T, Wang S, Xu Z, Zhang C, Zhao Y, Hu Y, et al. Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis. Sci Rep. 2015;5:8191.

    Article  CAS  Google Scholar 

  16. Liu Y, Zhang S, Li DW, Jiang SJ. Efficacy of anti-interleukin-5 therapy with mepolizumab in patients with asthma: a meta-analysis of randomized placebo-controlled trials. PLoS One. 2013;8(3):e59872.

    Article  CAS  Google Scholar 

  17. Lim HF, Nair P. Efficacy and safety of reslizumab in patients with moderate to severe eosinophilic asthma. Expert Rev Respir Med. 2015;9(2):135–42.

    Article  CAS  Google Scholar 

  18. Sheshadri A, Castro M, Chen A. Bronchial thermoplasty: a novel therapy for severe asthma. Clin Chest Med. 2013;34(3):437–44.

    Article  Google Scholar 

  19. Castro M, Musani AI, Mayse ML, Shargill NS. Bronchial thermoplasty: a novel technique in the treatment of severe asthma. Ther Adv Respir Dis. 2010;4(2):101–16.

    Article  Google Scholar 

  20. Wechsler ME, Laviolette M, Rubin AS, Fiterman J, Lapa e Silva JR, Shah PL, et al. Bronchial thermoplasty: long-term safety and effectiveness in patients with severe persistent asthma. J Allergy Clin Immunol. 2013;132(6):1295–302.

    Article  Google Scholar 

  21. Aysola RS, Hoffman EA, Gierada D, Wenzel S, Cook-Granroth J, Tarsi J, et al. Airway remodeling measured by multidetector CT is increased in severe asthma and correlates with pathology. Chest. 2008;134(6):1183–91.

    Article  Google Scholar 

  22. Bergeron C, Boulet LP. Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation. Chest. 2006;129(4):1068–87.

    Article  CAS  Google Scholar 

  23. Cohen L, E X TJ, Ramkumar T, Horiuchi TK, Cochran R, et al. Epithelial cell proliferation contributes to airway remodeling in severe asthma. Am J Respir Crit Care Med. 2007;176(2):138–45.

    Article  CAS  Google Scholar 

  24. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med. 2000;161(5):1720–45.

    Article  CAS  Google Scholar 

  25. Dyrda P, Tazzeo T, DoHarris L, Nilius B, Roman HN, Lauzon AM, et al. Acute response of airway muscle to extreme temperature includes disruption of actin-myosin interaction. Am J Respir Cell Mol Biol. 2011;44(2):213–21.

    Article  CAS  Google Scholar 

  26. Chakir J, Haj-Salem I, Gras D, Joubert P, Beaudoin EL, Biardel S, et al. Effects of bronchial thermoplasty on airway smooth muscle and collagen deposition in asthma. Ann Am Thorac Soc. 2015;12(11):1612–8.

    PubMed  Google Scholar 

  27. Pretolani M, Dombret MC, Thabut G, Knap D, Hamidi F, Debray MP, et al. Reduction of airway smooth muscle mass by bronchial thermoplasty in patients with severe asthma. Am J Respir Crit Care Med. 2014;190(12):1452–4.

    Article  Google Scholar 

  28. Denner DR, Doeing DC, Hogarth DK, Dugan K, Naureckas ET, White SR. Airway inflammation after bronchial thermoplasty for severe asthma. Ann Am Thorac Soc. 2015;12(9):1302–9.

    Article  Google Scholar 

  29. Castro M, Cox G. Asthma outcomes from bronchial thermoplasty in the AIR2 trial. Am J Respir Crit Care Med. 2011;184(6):743–4.

    Article  Google Scholar 

  30. Chupp G, Laviolette M, Cohn L, McEvoy C, Bansal S, Shifren A, et al. Long-term outcomes of bronchial thermoplasty in subjects with severe asthma: a comparison of 3-year follow-up results from two prospective multicentre studies. Eur Respirat J. 2017;50: (2)1700017.

    Google Scholar 

  31. Pavord ID, Cox G, Thomson NC, Rubin AS, Corris PA, Niven RM, et al. Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma. Am J Respir Crit Care Med. 2007;176(12):1185–91.

    Article  CAS  Google Scholar 

  32. Pavord ID, Thomson NC, Niven RM, Corris PA, Chung KF, Cox G, et al. Safety of bronchial thermoplasty in patients with severe refractory asthma. Ann Allergy Asthma Immunol. 2013;111(5):402–7.

    Article  Google Scholar 

  33. Pretolani M, Bergqvist A, Thabut G, Dombret MC, Knapp D, Hamidi F, et al. Effectiveness of bronchial thermoplasty in patients with severe refractory asthma: clinical and histopathologic correlations. J Allergy Clin Immunol. 2017;139(4):1176–85.

    Article  Google Scholar 

  34. Cox G, Thomson NC, Rubin AS, Niven RM, Corris PA, Siersted HC, et al. Asthma control during the year after bronchial thermoplasty. N Engl J Med. 2007;356(13):1327–37.

    Article  CAS  Google Scholar 

  35. Castro M, Rubin AS, Laviolette M, Fiterman J, De Andrade Lima M, Shah PL, et al. Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med. 2010;181(2):116–24.

    Article  Google Scholar 

  36. Castro M, Rubin A, Laviolette M, Hanania NA, Armstrong B, Cox G. Persistence of effectiveness of bronchial thermoplasty in patients with severe asthma. Ann Allergy Asthma Immunol. 2011;107(1):65–70.

    Article  CAS  Google Scholar 

  37. Katial RK, Bensch GW, Busse WW, Chipps BE, Denson JL, Gerber AN, et al. Changing paradigms in the treatment of severe asthma: the role of biologic therapies. J Allergy Clin Immunol Pract. 2017;5(2S):S1–S14.

    Article  Google Scholar 

  38. Sood S, Hall CB, Castro M. Imaging procedures and bronchial thermoplasty for asthma assessment and intervention. In: Szefler SJ, Wechsler ME, Holguin F, editors. Personalizing asthma management for the clinician. St. Louis: Elsevier; 2018. p. 191–205.

    Chapter  Google Scholar 

  39. Tirumalasetty J, Grammer LC. Asthma, surgery, and general anesthesia: a review. J Asthma. 2006;43(4):251–4.

    Article  Google Scholar 

  40. Leary D, Svenningsen S, Guo F, Bhatawadekar S, Parraga G, Maksym GN. Hyperpolarized 3He magnetic resonance imaging ventilation defects in asthma: relationship to airway mechanics. Physiologic reports. 2016;4:(7)e12761.

    Google Scholar 

  41. Svenningsen S, Kirby M, Starr D, Leary D, Wheatley A, Maksym GN, et al. Hyperpolarized (3) He and (129) Xe MRI: differences in asthma before bronchodilation. J Magnet Resonance Imaging. 2013;38(6):1521–30.

    Article  Google Scholar 

  42. Aysola R, de Lange EE, Castro M, Altes TA. Demonstration of the heterogeneous distribution of asthma in the lungs using CT and hyperpolarized helium-3 MRI. J Magnet Resonance Imaging 2010;32(6):1379–1387.

    Google Scholar 

  43. Thomen RP, Sheshadri A, Quirk JD, Kozlowski J, Ellison HD, Szczesniak RD, et al. Regional ventilation changes in severe asthma after bronchial thermoplasty with (3)He MR imaging and CT. Radiology. 2015;274(1):250–9.

    Article  Google Scholar 

  44. Bueno J, de Lange EE. Chapter 4 – persistence of ventilation defects in asthmatics A2 – Albert, Mitchell S. In: Hane FT, editor. Hyperpolarized and inert gas MRI. Boston: Academic Press; 2017. p. 61–70.

    Google Scholar 

  45. Cadman RV, Lemanske RF, Jr., Evans MD, Jackson DJ, Gern JE, Sorkness RL, et al. Pulmonary 3He magnetic resonance imaging of childhood asthma. J Allergy Clin Immunol. 2013;131(2):369–76.e1–5.

    Google Scholar 

  46. Witt CA, Sheshadri A, Carlstrom L, Tarsi J, Kozlowski J, Wilson B, et al. Longitudinal changes in airway remodeling and air trapping in severe asthma. Acad Radiol. 2014;21(8):986–93.

    Article  Google Scholar 

  47. Trivedi A, Hall C, Hoffman EA, Woods JC, Gierada DS, Castro M. Using imaging as a biomarker for asthma. J Allergy Clin Immunol. 2017;139(1):1–10.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Theresa W. Guilbert .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Zak, S., Benscoter, D., Castro, M., Guilbert, T.W. (2021). Bronchial Thermoplasty. In: Goldfarb, S., Piccione, J. (eds) Diagnostic and Interventional Bronchoscopy in Children. Respiratory Medicine. Humana, Cham. https://doi.org/10.1007/978-3-030-54924-4_42

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-54924-4_42

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-54923-7

  • Online ISBN: 978-3-030-54924-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics